What are the Historical Developments and Current Growth Metrics of the Bioprocess Automation Market?
The bioprocess automation market has seen considerable growth due to a variety of factors.
• In recent years, the bioprocess automation market has experienced a significant expansion. The market size is projected to increase from $5.67 billion in 2024 to $6.37 billion in 2025, with a compound annual growth rate of 12.2%.
Factors such as enhanced efficiency, cost savings, risk management, increasing need for remote monitoring and control, and decreased reliance on labor have contributed to the growth in the historic period.
What Is The Projected Growth Of The Bioprocess Automation Template Market?
The bioprocess automation market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for bioprocess automation is projected to experience significant expansion in the coming years, swelling to a value of $10.27 billion by 2029 with a compound annual growth rate (CAGR) of 12.7%.
This anticipated growth during the forecast period is largely due to improvements in productivity, adherence to regulatory standards, process optimization, predictive maintenance, and real-time analysis capabilities. Key trends expected over the forecast period encompass the incorporation of artificial intelligence and machine learning, modular bioprocessing techniques, process control methodologies for gene therapy, and advances in data analytics and visualization.
What Are The Key Drivers Fueling Growth In The Bioprocess Automation Market?
The rise in tailored medical treatments, often referred to as personalized medicines, is projected to propel the bioprocess automation market's advancement. This individualized medical approach customizes healthcare choices, strategies, interventions, and treatments to align with the unique attributes of each individual. The implementation of bioprocess automation greatly benefits personalized medicine as it guarantees precision and scalability in the manufacture of drugs specifically designed for each patient. As per the Personalized Medicine Coalition, a professional organization based in the US, the approval of 12 new personalized medicines in 2022, accounting for nearly 34% of all newly sanctioned therapies, signifies a significant escalation compared to earlier years. Hence, the escalating number of personalized medicines is bolstering the growth of the bioprocess automation market.
What Are The Principal Market Segments In The Global Bioprocess Automation Industry?
The bioprocess automation market covered in this report is segmented –
1) By Component Of Process Control System: Sensors, Actuators, Controllers
2) By Scale Of Operation: Preclinical Operations, Clinical Operations, Commercial Operations
3) By Mode Of Operation: Batch, Fed-Batch, Perfusion
4) By Compatibility With Bioprocessing Systems: Single-Use Systems, Stainless Steel, Other Bioprocessing Systems
Subsegments:
1) By Sensors: Temperature Sensors, Pressure Sensors, Flow Sensors, Level Sensors, PH Sensors, Other Sensors
2) By Actuators: Electric Actuators, Pneumatic Actuators, Hydraulic Actuators, Other Actuators
3) By Controllers: Programmable Logic Controllers (PLC), Distributed Control Systems (DCS), Supervisory Control And Data Acquisition (SCADA), Other Controllers
Pre-Book The Bioprocess Automation Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Bioprocess Automation Market?
Pioneering corporations in the bioprocess automation marketplace are focusing on creating innovative products, such as bioreactors, to streamline bioprocessing tasks. Bioreactors are purposely designed systems or implements that cultivate a favourable and regulated setting for chemical and biological functions. For example, Cytiva, a US technology company specializing in progressing and expedited therapeutic development and production, introduced X-platform bioreactors in April 2023. These are user-friendly, adaptable, and improve process efficiency. Initially, they were launched with capacities of 50 and 200 L. They promote operational efficiency through ergonomic enhancements, increased production potential, and streamlined supply chain processes. These X-platform bioreactors have applications in manufacturing cell and gene therapies, viral vectors, and monoclonal antibodies (mAbs).
Who Are the Key Players In The Bioprocess Automation Market?
Major companies operating in the bioprocess automation market are:
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Corporation
• Danaher Corporation
• Amgen Inc.
• Merck KGaA
• Parker-Hannifin Corporation
• CSL Behring LLC
• Rockwell Automation Inc.
• Agilent Technologies Inc.
• Lonza Group AG
• Waters Corporation
• Getinge AB
• Eppendorf AG
• Repligen Corporation
• BIONET Research S.A.
• Flotek Industries Inc.
• Pierre Guerin SAS
• Bioengineering AG
• Genedata AG
• ILS Automation
• INFORS AG
• Synthace Limited
• Automated Control Concepts Inc.
• BlueSens gas sensor GmbH
• DISTek Integration Inc.
• Securecell AG
• Flownamics Analytical Instruments Inc.
• Inscripta Inc.
• PendoTECH Inc.
• Sartorius Stedim Biotech S.A.
What Are The Regional Insights Into The Bioprocess Automation Market?
North America was the largest region in the bioprocess automation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess automation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
